Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
- PMID: 34785956
- PMCID: PMC8590980
- DOI: 10.2147/HIV.S337073
Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
Abstract
Introduction: Since the launch of universal "test and treat" approach in 2016, there has been a significant increase in persons initiated on antiretroviral therapy (ART) on the same-day of human immunodeficiency virus (HIV) diagnosis in low-income settings. However, there are limited studies that investigated the effect of rapid treatment initiation on adherence. In this study, we compared adherence to ART in people who started ART on the same-day of HIV diagnosis and those started more than 7 days after HIV diagnosis.
Methods: We conducted a retrospective cohort analysis using routinely collected data from multiple ART clinics. Participants were at least 15 years old, were newly diagnosed and started on ART between October 2016 and July 2018 in the Amhara region of Ethiopia. We used doubly-robust multivariable logistic regression model to estimate the adjusted effects on adherence.
Results: A total of 415 individuals who started ART on the same-day of HIV diagnosis and 527 individuals who started 7 days after their HIV diagnosis were included in the analysis. The proportion of participants who reported optimal adherence was significantly lower in the same-day group at 6- and 12-months (absolute risk difference of 6.5%; 95% CI: 1.1%, 11.9% and 6.8%; 95% CI: 1.2%, 12.5%, respectively) compared to the >7 days group. After adjusting for baseline and non-baseline covariates, the same-day group was less likely to have optimal adherence both at 6- and 12-months (adjusted RR=0.90; 95% CI: 0.86, 0.94 and RR=0.89; 95% CI: 0.83, 0.95, respectively) compared to the >7 days group.
Conclusion: We observed lower optimal adherence among individuals who started ART on the same-day of HIV diagnosis compared to those who started ART >7 days after their HIV diagnosis. Our findings highlight the importance of identifying adherence barriers, providing support, and ensuring treatment readiness before initiating individuals on same-day ART.
Keywords: Africa; Ethiopia; adherence; rapid ART; same-day antiretroviral therapy; test and treat.
© 2021 Ahmed et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Effectiveness of same-day antiretroviral therapy initiation in retention outcomes among people living with human immunodeficiency virus in Ethiopia: empirical evidence.BMC Public Health. 2020 Nov 26;20(1):1802. doi: 10.1186/s12889-020-09887-9. BMC Public Health. 2020. PMID: 33243185 Free PMC article.
-
Virologic outcomes of people living with human immunodeficiency virus who started antiretroviral treatment on the same-day of diagnosis in Ethiopia: A multicenter observational study.PLoS One. 2021 Sep 3;16(9):e0257059. doi: 10.1371/journal.pone.0257059. eCollection 2021. PLoS One. 2021. PMID: 34478438 Free PMC article.
-
Incidence and determinants of mortality among adult HIV infected patients on second-line antiretroviral treatment in Amhara region, Ethiopia: a retrospective follow up study.Pan Afr Med J. 2019 Jun 6;33:89. doi: 10.11604/pamj.2019.33.89.16626. eCollection 2019. Pan Afr Med J. 2019. PMID: 31489067 Free PMC article.
-
Same-day antiretroviral treatment (ART) initiation and associated factors among HIV positive people in Northwest Ethiopia: baseline characteristics of prospective cohort.Arch Public Health. 2020 Sep 22;78:87. doi: 10.1186/s13690-020-00473-4. eCollection 2020. Arch Public Health. 2020. PMID: 32983450 Free PMC article.
-
Same-day and rapid initiation of antiretroviral therapy in people living with HIV in Asia. How far have we come?HIV Med. 2022 Oct;23 Suppl 4:3-14. doi: 10.1111/hiv.13410. HIV Med. 2022. PMID: 36254390 Review.
Cited by
-
Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis.AIDS. 2025 Mar 1;39(3):241-252. doi: 10.1097/QAD.0000000000004046. Epub 2024 Oct 24. AIDS. 2025. PMID: 39453866 Free PMC article.
-
Rapid antiretroviral therapy and treatment outcomes among people living with HIV: exploring the mediating roles of medication adherence.Front Public Health. 2024 Oct 1;12:1420609. doi: 10.3389/fpubh.2024.1420609. eCollection 2024. Front Public Health. 2024. PMID: 39411493 Free PMC article.
-
Suboptimal adherence to antiretroviral treatment and its predictors among people living with HIV in the era of test and treat.Sci Rep. 2025 Apr 12;15(1):12666. doi: 10.1038/s41598-025-96631-1. Sci Rep. 2025. PMID: 40221467 Free PMC article.
-
Predicting antiretroviral therapy adherence status of adult HIV-positive patients using machine-learning Northwest, Ethiopia, 2025.BMC Med Inform Decis Mak. 2025 Jul 10;25(1):259. doi: 10.1186/s12911-025-03106-4. BMC Med Inform Decis Mak. 2025. PMID: 40640758 Free PMC article.
References
-
- UNAIDS. Global AIDS update 2020: seizing the moment; 2020. Available from: https://aids2020.unaids.org/report/. Accessed September 29, 2020.
-
- UCSF. Adherence to HIV antiretroviral therapy; 2006. Available from: http://hivinsite.ucsf.edu/InSite?page=kb-03-02-09#S3X. Accessed February 12, 2019.
LinkOut - more resources
Full Text Sources